684 | MECAPEGFILGRASTIM FOR PROPHYLAXIS OF CHEMOTHERAPY‐INDUCED NEUTROPENIA IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA: A MULTICENTER PILOT TRIAL

Documenti analoghi

• 278 | ASSESSING THE EFFICACY AND TOXICITY OF CNS PROPHYLAXIS IN DIFFUSE LARGE B‐CELL LYMPHOMA (CLSG‐CNS‐01): A RANDOMIZED, MULTICENTER, PROSPECTIVE PHASE 3 TRIAL
  di: H. Mocikova, et al.
  Pubblicazione: (2025)
• 815 | GLOFITAMAB MONOTHERAPY IN CHINESE PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: FINAL ANALYSIS OF A PHASE I TRIAL
  di: Y. Song, et al.
  Pubblicazione: (2025)
• 335 | THE IMPACT OF CONSOLIDATION TREATMENT AFTER R‐MVP INDUCTION CHEMOTHERAPY IN PATIENTS WITH PRIMARY DIFFUSE LARGE B‐CELL LYMPHOMA OF THE CNS
  di: J. Lee, et al.
  Pubblicazione: (2025)
• 639 | DIFFUSE LARGE B CELL LYMPHOMA: A TUNISIAN MULTICENTER EXPERIENCE
  di: M. A. Laatiri, et al.
  Pubblicazione: (2025)
• 674 | CLINICOPATHOLOGICAL CHARACTERISTICS, TREATMENT RESPONSE, AND PROGNOSTIC FACTORS OF PATIENTS WITH INTRAVASCULAR LARGE B CELL LYMPHOMA: A MULTICENTER STUDY IN CHINA
  di: Y. Guo, et al.
  Pubblicazione: (2025)